Back to Report Store Home

Global Respiratory Complications Therapeutics Market to 2022 - Innovative Pneumonia and Pulmonary Arterial Hypertension Therapies Dominate Varied Disease Market

  • Published: Mar-2017
  • Report Code: GBIHC433MR
  • Report Format: pdf

Description

List of Figures

Figure 1: Respiratory Complications Therapeutics Market, Global, Epidemiology Patterns for Pneumonia Incidence, 2015–2022 17

Figure 2: Respiratory Complications Therapeutics Market, Global, Epidemiology Patterns for Pneumococcal Vaccinations (million), 2015–2022 18

Figure 3: Respiratory Complications Therapeutics Market, Global, Epidemiology Patterns for PAH, 2015–2022 19

Figure 4: Respiratory Complications Therapeutics Market, Global, Epidemiology Patterns for Tuberculosis, 2015–2022 19

Figure 5: Respiratory Complications Therapeutics Market, Global, Prevnar 13 Revenue Forecast, 2015–2022 31

Figure 6: Respiratory Complications Therapeutics Market, Global, Synflorix Revenue Forecast, 2015–2022 32

Figure 7: Respiratory Complications Therapeutics Market, Global, Uptravi Revenue Forecast, 2016–2022 33

Figure 8: Respiratory Complications Therapeutics Market, Global, Opsumit Revenue Forecast, 2015–2022 34

Figure 9: Respiratory Complications Therapeutics Market, Global, Eliquis Revenue Forecast, 2015–2022 35

Figure 10: Respiratory Complications Therapeutics Market, Global, Xarelto Revenue Forecast, 2015–2022 37

Figure 11: Respiratory Complications Therapeutics Market, Global, Synagis Revenue Forecast, 2015–2022 38

Figure 12: Respiratory Complications Therapeutics Market, Global, Ventolin Revenue Forecast, 2015–2022 39

Figure 13: Respiratory Complications Therapeutics Market, Global, Infanrix Revenue Forecast, 2015–2022 40

Figure 14: Respiratory Complications Therapeutics Market, Global, Boostrix Revenue Forecast, 2015–2022 41

Figure 15: Respiratory Complications Therapeutics Market, Global, Pipeline by Stage of Development, Molecule Type and Program Type, 2017 43

Figure 16: Respiratory Complications Therapeutics Market, Global, Pipeline for Key Indications by Stage of Development, 2017 44

Figure 17: Respiratory Complications Therapeutics Market, Global, Pipeline for Key Indications by Molecule Type, 2017 45

Figure 18: Respiratory Complications Therapeutics Market, Global, Pipeline by Molecular Target, 2017 47

Figure 19: Respiratory Complications Therapeutics Market, Global, Pipeline for Key Indications by Molecular Target, 2017 48

Figure 20: Respiratory Complications Therapeutics Market, Global, Clinical Trial Attrition Rates by Stage of Development (%), 2006–2017 49

Figure 21: Respiratory Complications Therapeutics Market, Global, Clinical Trial Attrition Rates by Stage of Development and Indication (%), 2006–2017 50

Figure 22: Respiratory Complications Therapeutics Market, Global, Clinical Trial Attrition Rates by Stage of Development and Molecule Type (%), 2006–2017 51

Figure 23: Respiratory Complications Therapeutics Market, Global, Clinical Trial Attrition Rates by Stage of Development and Molecular Target (%), 2006–2017 52

Figure 24: Respiratory Complications Therapeutics Market, Global, Clinical Trial Duration by Stage of Development (months), 2006–2017 53

Figure 25: Respiratory Complications Therapeutics Market, Global, Clinical Trial Duration by Stage of Development and Indication (months), 2006–2017 54

Figure 26: Respiratory Complications Therapeutics Market, Global, Clinical Trial Duration by Stage of Development and Molecule Type (months), 2006–2017 55

Figure 27: Respiratory Complications Therapeutics Market, Global, Clinical Trial Duration by Stage of Development and Molecular Target (months), 2006–2017 56

Figure 28: Respiratory Complications Therapeutics Market, Global, Clinical Trial Size by Stage of Development (participants), 2006–2017 56

Figure 29: Respiratory Complications Therapeutics Market, Global, Clinical Trial Size by Stage of Development and Indication (participants), 2006–2017 57

Figure 30: Respiratory Complications Therapeutics Market, Global, Clinical Trial Size by Stage of Development and Molecule Type (participants), 2006–2017 58

Figure 31: Respiratory Complications Therapeutics Market, Global, Clinical Trial Size by Stage of Development and Molecular Target (participants), 2006–2017 59

Figure 32: Respiratory Complications Therapeutics Market, Global, Clinical Program Size by Stage of Development (participants), 2006–2017 60

Figure 33: Respiratory Complications Therapeutics Market, Global, Clinical Program Size by Stage of Development and Indication (participants), 2006???2017 60

Figure 34: Respiratory Complications Therapeutics Market, Global, Clinical Program Size by Stage of Development and Molecule Type (participants), 2006–2017 61

Figure 35: Respiratory Complications Therapeutics Market, Global, Clinical Program Size by Stage of Development and Molecular Target (participants), 2006–2017 62

Figure 36: Respiratory Complications Therapeutics Market, Global, Revenue Forecast for Solithera ($m), 2017–2022 64

Figure 37: Respiratory Complications Therapeutics Market, Global, Revenue Forecast for Carbavance ($m), 2017–2022 65

Figure 38: Respiratory Complications Therapeutics Market, Global, Revenue for Respiratory Syncytial Virus Vaccine ($m), 2018–2022 66

Figure 39: Respiratory Complications Therapeutics Market, Global, Market Size ($bn), 2015–2022 68

Figure 40: Respiratory Complications Therapeutics Market, Global, Annual Revenue by Generic Products ($m), 2015–2022 70

Figure 41: Respiratory Complications Therapeutics Market, Global, Annual Revenue Forecast for Vaccines ($bn), 2015–2022 71

Figure 42: Respiratory Complications Therapeutics Market, Global, Annual Revenue Forecast for Drugs Targeting G-Protein Coupled Receptors ($bn), 2015–2022 71

Figure 43: Respiratory Complications Therapeutics Market, Global, Annual Revenue Forecast for Drugs Targeting Enzymes ($bn), 2015–2022 72

Figure 44: Respiratory Complications Therapeutics Market, Global, Annual Revenue Forecast for Drugs with Bacterial/Viral Targets ($bn), 2015–2022 73

Figure 45: Respiratory Complications Therapeutics Market, Global, Company Analysis Matrix, 2015–2022 74

Figure 46: Respiratory Complications Therapeutics Market, Global, Forecast Market Share by Company (%), 2015–2022 76

Figure 47: Respiratory Complications Therapeutics Market, Global, Companies by Compound Annual Growth Rate (%), Base Year–2022 77

Figure 48: Respiratory Complications Therapeutics Market, Global, Pfizer Annual Revenue Forecast ($bn), 2015–2022 78

Figure 49: Respiratory Complications Therapeutics Market, Global, Actelion Annual Revenue ($bn), 2015–2022 79

Figure 50: Respiratory Complications Therapeutics Market, Global, GSK Annual Revenue ($bn), 2015–2022 80

Figure 51: Respiratory Complications Therapeutics Market, Global, Bayer Annual Revenue ($bn), 2015–2022 81

Figure 52: Respiratory Complications Therapeutics Market, Global, Bristol-Myers Squibb Annual Revenue ($bn), 2015–2022 82

Figure 53: Respiratory Complications Therapeutics Market, Global, Novavax Annual Revenue ($m), 2018–2022 83

Figure 54: Respiratory Complications Therapeutics Market, Global, United Therapeutics Annual Revenue ($bn), 2015–2022 84

Figure 55: Respiratory Complications Therapeutics Market, Global, Cluster by Growth and Market Share, 2015–2022 85

Figure 56: Respiratory Complications Therapeutics Market, Global, Companies by Type, 2017 86

Figure 57: Respiratory Complications Therapeutics Market, Global, High-Activity and Late-Stage Developers by Level of Specialization, 2017 87

Figure 58: Respiratory Complications Therapeutics Market, Global, Proportion of Total Company Revenue Attributed to Respiratory Complications, 2015–2022 88

 
      captcha refresh

I have read and accept terms and conditions and privacy policy

Cancel
License Details
Electronic PDF copy delivered via email. Report can be used by individual purchaser only.
Single User Licence
$4995
Electronic PDF copy delivered via email. Report can be shared by unlimited users within one corporate location, e.g. a regional office.
Site Licence
$9990
Electronic PDF copy delivered via email. Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company.
Global Licence
$14985
Email to a colleague Request Sample Pages Enquire Before Buying
Prefer to speak to a team member? Call us on:
+44 161 359 5817
Or click here to contact us
Secure Payments
Cards